http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021098506-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84db81219dc96b04151829e105925291
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y103-99006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-53
filingDate 2020-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97fcf1b6bfe9bbe160f642f93273c3c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97e432b4f9f8ff9842ff37206971a99e
publicationDate 2021-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021098506-A1
titleOfInvention STEROID 5β REDUCTASE VARIANT AND APPLICATION THEREFOR
abstract A steroid 5β reductase variant and an application therefor. The steroid 5β reductase variant has steroid 5β reductase activity, and the amino acid sequence of the variant includes R63K and R64H mutations. The variant can use NADH as a coenzyme, and has an amino acid sequence selected from the group consisting of: 1) an amino acid sequence as indicated in SEQ ID NO: 1, 3 or 5; 2) an amino acid sequence produced by an amino acid sequence as indicated in SEQ ID NO: 1, 3 or 5 going through the substitution, deletion or addition of one or a plurality of amino acids; or 3) an amino acid sequence that has 69% or more of its sequence in common with SEQ ID NO: 1, 3 or 5. The transformation product of the steroid 5β reductase variant has a single conformation and only has a β-type reduction product that occurs, the reductase has spatial hydrogenation specificity, and the product does not contain an α-type structure. The variant is efficient and stable.
priorityDate 2019-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007298456-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101565709-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451539483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547023

Total number of triples: 44.